Welcome, visitor! [ Register | Login

Post an IOI
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Join Clearing and Settlement Now!

Value of Assets Posted

Est. over 8+ Billion in assets posted

IBKR

Featured Service Providers

  • ACSA
  • FirstBank Nigeria
  • CSOB
  • Screen Shot 2012-09-06 at 12.30.19 PM
  • Confidebat
  • Eurex Clearing
  • Orbis
  • KDPW_CCP
  • Escrow.com

Activity

  • Public Info posted an update 1 month, 3 weeks ago

    InvestorNewsBreak

    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results

    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results

    Home / InvestorWire NewsRoom / InvestorNewsBreaks /

    October 11, 2021

    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results

    TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it will release financial results for the third quarter of 2021 after market close on Oct. 25, 2021. According to the update, management will host a conference call and webcast, also on Oct. 25, at 5:00 p.m. Eastern Time to discuss the results. The call will conclude with a question-and-answer session with participants. Interested parties may join the call by dialing 1-877-425-9470 (U.S.) or 1-201-389-0878 (international) and entering conference ID: 13723384. Additionally, participants should visit https://ibn.fm/63FqK to access the webcast and are asked to dial in at least 10 minutes before the start of the call to ensure timely participation. A playback of the call will be available through Nov. 25, 2021, by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (international) and entering replay pin number 13723384.

    To view the full press release, visit https://ibn.fm/JzvNY

    About TRxADE Health Inc.

    TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving a total of 12,700+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For info on TRxADE HEALTH, please visit the company’s IR website at investors.trxadegroup.com.

    NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

    About InvestorWire

    InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

    With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

    Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

    For more information, please visit https://www.InvestorWire.com

    Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

    InvestorWire (IW)
    8033 Sunset Blvd Suite 1037-IW
    Los Angeles, CA 90046
    310.299.1717 Office
    http://www.InvestorWire.com
    Editor@InvestorWire.com

    InvestorWire is part of the InvestorBrandNetwork.

    Video courtesy of Escrow.com

Stock Investor Daily

Premium Wordpress Themes